Orai1 downregulation impairs lymphocyte function in type 2 diabetes mellitus
Orai1 downregulation impairs lymphocyte function in type 2 diabetes mellitus
复制标题
Orai1 下调损害 2 型糖尿病患者的淋巴细胞功能
DOI:
10.1016/j.bbrc.2018.04.083
复制
发表时间:
2018
影响因子:
3.1
通讯作者:
Luo Dali
中科院分区:
文献类型:
--
作者:
Wang Haoyang;Wang Cong;Wang Limin;Liu Tiantian;Wang Zhigiang;You Hongjie;Zheng Yuanyuan;Luo Dali
Background/AimsIt has been suggested that diabetes is associated with immune dysfunction, in which Ca2+signaling malfunction in lymphocyte may contributes most. However, the pattern of the Ca2+signal disorder and the mechanism(s) that explains the change are unclear. Here, in this study we aimed to investigate possible changes and mechanism(s) accounting for the internal Ca2+signals in diabetic T lymphocyte upon stimulation.Methods and resultsUsing Fura-2-AM, we found a significant decrease in Ca2+influx induced by thapsigargin (TG) and anti-CD3 antibody (OKT3) in T lymphocytes from blood of both diabetes patients and animals. Furthermore, a downregulated Orai1 protein expression, but not mRNA, was also observed in these cells using western blot and qRT-PCR, respectively. In addition, in high-glucose and agonist treated Jurkat T cells, Ca2+entry and the release of interleukin-2 (IL-2) were also decreased. Orai1 expression reduced, while stromal interaction molecule 1 (STIM1) and other downstream proteins remained unchanged.ConclusionThis study demonstrates that the declined Orai1 expression, at least partly, contributes to the downregulated Ca2+entry during lymphocyte excitation, providing an important mechanism for T lymphocyte malfunction in diabetes.